(3) Prepare ratio analyses (for 2020, 2019, and 2018) for both companie include the following ratios in your computations: Profitability ratios o Gross Profit margin Profit margin o Return on assets o Return on equity Productivity o Inventory Turnover Accounts Receivable Turnover o o PPE Turnover o Asset Turnover Solvency o Debt-to-equity o Times interest earned o Return on Financial leverage Liquidity o Current Ratio o Quick Ratio o Operating cash flow to current liabilities o Working capital USE 2017 INFORMATION ONLY FOR CALCULATION OF RATIOS Bristol Myers Squibb Co. (NYS: BMY) Report Date Cash & cash equivalents Marketable debt securites Receivables, net Inventories, net Prepaid expenses & other current assets Total current assets Property, plant & equipment, net Goodwill Other intangible assets Deferred income taxes 2020 2019 2018 2017 14,546 12.346 6.911 5421 1.285 3047 1,973 1.391 8.501 7585 5.965 6.300 2.074 4.293 1,150 1,100 3786 1.983 1.116 576 30,192 29.354 17,160 14.854 5.386 6252 5.027 5001 20.547 22.488 6,538 6863 53.243 63.969 1,001 1210 1,161 510 1.371 1610 433 767 1,775 2.480 7019 6604 2,024 1533 118,481 129,944 34,906 33,551 Marketable debt securities Other non-current assets Total assets Liabilities Short-term debt obligations 2:340 3.346 1,700 967 Accounts payable 2.713 2445 1,092 2248 Other current liabilities 14027 12:513 7,059 6.328 Total current liabilities 19.000 18.304 10,654 9.563 Deferred income taxes Long-term debt Other non-current liablines 5407 6454 4.550 5.166 48336 43.367 5,646 6975 7376 80,599 10.101 78.246 20,859 21,704 Total liabilities Stockholders' Equity Common stock 292 292 221 221 Capital in excess of par value of stock 44.325 43.709 2,061 1398 Accumulated other comprehensive income (loss) -1.539 -1.520 -2.762 -2.289 Retained earnings 21.281 34.474 34,065 31.160 Less cost of treasury stock 26.237 25.357 19.574 19.249 Non-controlling interest 60 100 96 106 Total equity 37,882 51.690 14,127 11.847 USE 2017 INFORMATION ONLY FOR CALCULATION OF RATIOS 2020 2019 2018 2017 14,546 12.346 6.911 5.421 1.285 3:047 1,973 1.391 8.501 7.685 5,965 6.300 2.074 4.293 1,196 1,160 3.786 1983 1.116 576 30,192 29.354 17,160 14854 5.886 6252 5.027 5.001 20.547 22.488 6,538 6,863 53.243 63.969 1,091 1210 1.161 510 1.371 1610 433 767 1,775 2.480 7.019 6.604 2.024 1.533 115,481 129,944 34,986 33.551 Bristol Myers Squibb Co. (NYS: BMY) Report Date Cash & cash equivalents Marketable debt securities Receivables, net Inventories, net Prepaid expenses & other curent assets Total current assets Property, plant & equipment, nat Goodwill Other intangible assets Deferred income taxes Marketable debt securites Other non-current assets Total assets Liabilities Short-term debt obligations 2.340 3.346 1,703 087 Accounts payable 2713 2445 1,892 2.248 Other current liabilities 14.027 12.513 7.059 6.328 Total current liabilities 19,000 18.304 10,654 9.563 Deferred income taxes Long-term debt Other non-current liabilities 5407 6454 4,559 5.166 48.336 43.307 5,640 6975 7,776 10.101 80.599 78.246 20,859 21,704 Total liabilities Stockholders' Equity Common stock 292 292 221 221 Capital in excess of par value of stock 44.325 43.709 2,081 Accumulated other comprehensive income (loss) -1839 -1520 -2,762 1898 -2.289 Retained earnings 21.281 34.474 34,065 31.160 Less cost of treasury stock 25.237 25.357 19,574 19.249 Non-controlling interest 60 100 106 Total equity 37.882 51.698 14,127 11,847 Balance Sheet income statement Additional Data USE 2017 INFORMATION ONLY FOR CALCULATION OF RATIOS. Pfizer Inc (NYS: PFE) Report Date Cash & cash equivalents Short-term investments Trade accounts receivable Inventories Current tax assets Other current assets Assets held for sale Total current assets Equity-method investments Long-term investments Property, plant & equipment 2020 1,784,000 2019 1,305,000 2018 10,437,000 8,525,000 1,139,000 17,694,000 2017 1,342,000 18,650,000 7,930,000 8.724,000 8,025,000 8,221,000 8,047,000 8,284,000 7,508,000 7,577,000 3,264,000 3,344,000 3,374,000 3,050,000 3,438,000 2,600,000 2,461,000 2,289,000 167,000 21,000 9,725,000 12,000 35,067,000 32,803,000 49,926,000 41,141,000 16,856,000 17,133,000 3,406,000 3,014,000 2,767,000 7,015.000 13,900,000 13,967,000 13,385,000 13,865,000 Identifiable intangible assets 28,471,000 35,370,000 35,210,000 48,742,000 Goodwill 49,577,000 58,653.000 53,411,000 55,952,000 Noncurrent deferred tax assets & other noncurrent tax assets 2,383,000 2,099,000 1,924,000 1,855,000 Other noncurrent assets 4,569,000 4,450,000 2,799,000 3,227,000 Total assets 154,229,000 167,489,000 159,422,000 171,797,000 Liabilities Short-term borrowings, including current portion of long-term debt 2,703,000 16,195,000 8,831,000 Trade accounts payable 4,309,000 4,220,000 4,674,000 9,953,000 4,656,000 Dividends payable 2,162,000 2,104,000 2,047,000 2,029,000 Income taxes payable 1,049,000 980,000 1,265,000 477,000 Accrued compensation & related items 3,057,000 2.722.000 2,398,000 2,197,000 Other current liabilities 12,640,000 11,083,000 12,643,000 11,115,000 Total current liabilities 25,920,000 37,304,000 31,858,000 30,427,000 Long-term debt 37.133,000 35.955,000 32,909,000 33.538,000 Pension benefit obligations 4,766,000 5,638,000 5,272,000 5.926,000 Postretirement benefit obligations 645,000 1,124,000 1,338,000 1,504,000 Noncurrent deferred tax liabilities 4,063,000 5,578,000 3,700,000 3,900,000 Other taxes payable 11,560,000 12.126,000 14,737,000 18,697,000 Other noncurrent liabilities 6,669,000 6,317,000 Total liabilities 90,756,000 104,042,000 5,850,000 95,664,000 6,149,000 100,141,000 Stockholders' Equity Preferred stock 0 Common stock 470,000 Additional paid-in capital 88,674,000 Treasury stock 110,988,000 Retained earnings (accumulated deficit) 96,770,000 Accumulated other comprehensive income (loss) -11,688,000 Equity attributable to noncontrolling interests 235,000 Total equity (deficit) 63,473,000 17,000 468,000 19,000 467,000 87,428,000 86,253,000 21,000 464,000 84,278,000 110,801,000 101,610,000 89,425,000 97,670,000 89,554,000 -11,640,000 305,000 63,447,000 -11,275,000 350,000 63,758,000 85,291,000 9,321,000 348,000 71,656,000 analyze in words the coverage and liquidity of the following for 2020, 2019 and 2018